Faes Farma, S.A. (BME:FAE)
Spain · Delayed Price · Currency is EUR 4.215
+0.090 (2.18%)
Sep 3, 2025, 4:44 PM CET
Faes Farma Market Cap
Faes Farma has a market cap or net worth of €1.28 billion as of September 3, 2025. Its market cap has increased by 13.33% in one year.
Market Cap
1.28B
Enterprise Value
1.26B
Revenue
543.77M
Ranking
n/a
PE Ratio
12.24
Stock Price
€4.22
Market Cap Chart
Since March 1, 1994, Faes Farma's market cap has increased from 163.59M to 1.28B, an increase of 684.84%. That is a compound annual growth rate of 6.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 1.28B | 18.54% |
| Dec 31, 2024 | 1.08B | 9.15% |
| Dec 29, 2023 | 992.31M | -7.61% |
| Dec 30, 2022 | 1.07B | 5.44% |
| Dec 30, 2021 | 1.02B | 3.90% |
| Dec 31, 2020 | 980.37M | -28.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Grifols | 7.33B |
| Laboratorios Farmaceuticos Rovi | 2.97B |
| Almirall | 2.40B |
| Pharma Mar | 1.43B |
| Clínica Baviera | 747.17M |
| Laboratorio Reig Jofre | 223.80M |
| Atrys Health | 215.61M |
| Oryzon Genomics | 206.96M |